DESCRIPTIVES | MALES (N = 243) | FEMALES (N = 44) | ||
---|---|---|---|---|
 | (%) | Mean ± SD | (%) | Mean ± SD |
Age at recruitment |  | 57.2 ± 8.7 |  | 57.82 ± 7.59 |
Body Mass Index (kg/m2) |  | 25.63 ± 3.8 |  | 28.38 ± 5.4 |
Waist-Hip-Ratio |  | 0.96 ± 0.05 |  | 0.87 ± 0.09 |
Diabetes | 44.9 | Â | 67.4 | Â |
Hypertension | 48.2 | Â | 72.1 | Â |
Smoking | 47.3 | Â | - | Â |
Total cholesterol |  | 156.73 ± 39.3 |  | 166.23 ± 36.72 |
Triglycerides |  | 149.39 ± 75.3 |  | 150.59 ± 52.02 |
High Density lipoprotein |  | 37.86 ± 9.49 |  | 39.91 ± 8.75 |
Low Density Lipoprotein |  | 88.88 ± 33.29 |  | 96.17 ± 35.43 |
Apolipoprotein A1 |  | 1.12 ± 0.24 |  | 1.18 ± 0.18 |
Apolipoprotein B100 |  | 0.92 ± 0.26 |  | 0.93 ± 0.20 |
Age at onset of CAD |  | 51.34 ± 8.6 |  | 53.64 ± 7.8 |
Event score | Â | Â | Â | Â |
1 (Mild) | 3.9 | Â | 4.8 | Â |
2 (Moderate) | 27.6 | Â | 28.6 | Â |
3 (Severe) | 68.4 | Â | 66.7 | Â |
No. of disease vessels | Â | Â | Â | Â |
1 | 16.9 | Â | 23.3 | Â |
2 | 21.9 | Â | 30.0 | Â |
≥ 3 | 61.2 |  | 46.4 |  |
Statin therapy | 62.6 | Â | 78.3 | Â |
Beta blockers | 55.7 | Â | 69.6 | Â |
ACE inhibitors | 32.8 | Â | 41.3 | Â |
Calcium Channel blockers | 37.3 | Â | 23.9 | Â |
Hypoglycemic agents | 32.8 | Â | 36.9 | Â |